Tapewire

Nasdaq · USD

SRRK

Scholar Rock Holding Corp

Export transactions ↓
Tapewire entity
3721
SEC CIK
0001727196
Parsed reports
320

Last 12 months

Inside the activity.

0 purchase rows · 38 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 2026011
Feb 202607
Mar 202600
Apr 202604
May 202600
Jun 202600
Jul 2026013
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 07, 2024 Filed Oct 8, 2024 01:52 UTC SaleCommon Stock 31,250 $29.05 $907,812.50
Disclosure

SEC source: 0001104659-24-106804 · tm2425794-1_4seq1.xml · nonDerivative · entry 5

Myles Edward H · CIK 0001358219 · COO & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 161,088

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2024.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 01:52 UTC SaleCommon Stock 25,812 $27.27 $703,893.24
Disclosure

SEC source: 0001104659-24-106804 · tm2425794-1_4seq1.xml · nonDerivative · entry 4

Myles Edward H · CIK 0001358219 · COO & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 192,338

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.15 to $27.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 01:52 UTC SaleCommon Stock 37,206 $26.83 $998,236.98
Disclosure

SEC source: 0001104659-24-106804 · tm2425794-1_4seq1.xml · nonDerivative · entry 3

Myles Edward H · CIK 0001358219 · COO & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 218,150

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.15 to $27.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 01:52 UTC SaleCommon Stock 111,972 $25.61 $2,867,602.92
Disclosure

SEC source: 0001104659-24-106804 · tm2425794-1_4seq1.xml · nonDerivative · entry 2

Myles Edward H · CIK 0001358219 · COO & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 255,356

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $26.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 01:52 UTC Exercise / conversionCommon Stock 206,240 $13.83 $2,852,299.20
Disclosure

SEC source: 0001104659-24-106804 · tm2425794-1_4seq1.xml · nonDerivative · entry 1

Myles Edward H · CIK 0001358219 · COO & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 367,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2024.

F1 · shares: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2024.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 01:03 UTC
Sacco TraceyCHIEF COMMERCIAL OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001104659-24-106801 · tm2425784-1_4seq1.xml · derivative · entry 4

Sacco Tracey · CIK 0001980334 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,625

Underlying: Common Stock · 30,000 shares

Expires 2033-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Options vest over four years with 25% vesting on February 6, 2024 and the remainder vesting in 12 quarterly installments thereafter, provided the reporting person continues to have a service relationship with the Issuer on such vesting date.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 01:03 UTC
Sacco TraceyCHIEF COMMERCIAL OFFICER
SaleCommon Stock 1,964 $26.23 $51,515.72
Disclosure

SEC source: 0001104659-24-106801 · tm2425784-1_4seq1.xml · nonDerivative · entry 3

Sacco Tracey · CIK 0001980334 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,285

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 01:03 UTC
Sacco TraceyCHIEF COMMERCIAL OFFICER
SaleCommon Stock 28,036 $25.58 $717,160.88
Disclosure

SEC source: 0001104659-24-106801 · tm2425784-1_4seq1.xml · nonDerivative · entry 2

Sacco Tracey · CIK 0001980334 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,249

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $26.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 01:03 UTC
Sacco TraceyCHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 30,000 $10.00 $300,000.00
Disclosure

SEC source: 0001104659-24-106801 · tm2425784-1_4seq1.xml · nonDerivative · entry 1

Sacco Tracey · CIK 0001980334 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,285

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2024.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 00:55 UTC SaleCommon Stock 155,713 $32.50 $5,060,672.50
Disclosure

SEC source: 0001415889-24-024852 · form4-10082024_121030.xml · nonDerivative · entry 3

AKKARAJU SRINIVAS · CIK 0001253170 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Samsara BioCapital, L.P.

Disclosed balance after: 5,612,896

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Samsara LP on June 10, 2024.

F2 · ownership.nature: Shares held by Samsara BioCapital LP ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 00:55 UTC SaleCommon Stock 510,000 $30.00 $15,300,000.00
Disclosure

SEC source: 0001415889-24-024852 · form4-10082024_121030.xml · nonDerivative · entry 2

AKKARAJU SRINIVAS · CIK 0001253170 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Samsara BioCapital, L.P.

Disclosed balance after: 5,768,609

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Samsara LP on June 10, 2024.

F2 · ownership.nature: Shares held by Samsara BioCapital LP ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 00:55 UTC SaleCommon Stock 510,000 $27.50 $14,025,000.00
Disclosure

SEC source: 0001415889-24-024852 · form4-10082024_121030.xml · nonDerivative · entry 1

AKKARAJU SRINIVAS · CIK 0001253170 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Samsara BioCapital, L.P.

Disclosed balance after: 6,278,609

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Samsara LP on June 10, 2024.

F2 · ownership.nature: Shares held by Samsara BioCapital LP ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 00:51 UTC
Marantz Jing L.CHIEF MEDICAL OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 109,375 $0.00 Strike: $8.59 $0.00
Disclosure

SEC source: 0001104659-24-106797 · tm2425784-2_4seq1.xml · derivative · entry 5

Marantz Jing L. · CIK 0001834528 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,625

Underlying: Common Stock · 109,375 shares

Expires 2032-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Options vest over four years with 25% vesting on November 9, 2023 and the remainder vesting in 12 quarterly installments thereafter, provided the reporting person continues to have a service relationship with the Issuer as of the applicable vesting date.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 00:51 UTC
Marantz Jing L.CHIEF MEDICAL OFFICER
SaleCommon Stock 39,375 $30.06 $1,183,651.88
Disclosure

SEC source: 0001104659-24-106797 · tm2425784-2_4seq1.xml · nonDerivative · entry 4

Marantz Jing L. · CIK 0001834528 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,855

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on April 19, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 00:51 UTC
Marantz Jing L.CHIEF MEDICAL OFFICER
SaleCommon Stock 2,552 $26.22 $66,922.63
Disclosure

SEC source: 0001104659-24-106797 · tm2425784-2_4seq1.xml · nonDerivative · entry 3

Marantz Jing L. · CIK 0001834528 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,230

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on April 19, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.335, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 00:51 UTC
Marantz Jing L.CHIEF MEDICAL OFFICER
SaleCommon Stock 67,448 $25.59 $1,725,893.15
Disclosure

SEC source: 0001104659-24-106797 · tm2425784-2_4seq1.xml · nonDerivative · entry 2

Marantz Jing L. · CIK 0001834528 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,782

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on April 19, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $26.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 00:51 UTC
Marantz Jing L.CHIEF MEDICAL OFFICER
Exercise / conversionCommon Stock 109,375 $8.59 $939,531.25
Disclosure

SEC source: 0001104659-24-106797 · tm2425784-2_4seq1.xml · nonDerivative · entry 1

Marantz Jing L. · CIK 0001834528 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 182,230

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on April 19, 2024.

Read SEC document
September 16, 2024 Filed Sep 19, 2024 12:15 UTC
Qatanani MoCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 1,936 $8.58 $16,610.88
Disclosure

SEC source: 0001415889-24-023672 · form4-09192024_120935.xml · nonDerivative · entry 1

Qatanani Mo · CIK 0001980298 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,768

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on September 15, 2024. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on October 26, 2021 and October 10, 2022. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.

F2 · balance_after: Consists of 20,202 shares of common stock and 122,566 RSUs.

Read SEC document
August 16, 2024 Filed Aug 19, 2024 17:00 UTC SaleCommon Stock 1,451 $9.33 $13,537.83
Disclosure

SEC source: 0001104659-24-090887 · tm2422053-1_4seq1.xml · nonDerivative · entry 1

Parlavecchio Caryn · CIK 0001922346 · CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,988

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on August 15, 2024. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on October 26, 2021. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.

F2 · balance_after: Consists of 39,819 shares of common stock and 112,169 RSUs.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:30 UTC
Peng KatieDirector
GrantStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $8.36 $0.00
Disclosure

SEC source: 0001415889-24-018645 · form4-07012024_090712.xml · derivative · entry 2

Peng Katie · CIK 0001983850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2034-06-27

F3 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:30 UTC
Peng KatieDirector
GrantCommon Stock 4,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-018645 · form4-07012024_090712.xml · nonDerivative · entry 1

Peng Katie · CIK 0001983850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,325

F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

F2 · balance_after: Consists of 2,980 shares of common stock and 28,345 RSUs.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:31 UTC
Reed JoshuaDirector
GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.36 $0.00
Disclosure

SEC source: 0001415889-24-018647 · form4-07012024_090733.xml · derivative · entry 2

Reed Joshua · CIK 0001746541 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2034-06-27

F3 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:31 UTC
Reed JoshuaDirector
GrantCommon Stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-018647 · form4-07012024_090733.xml · nonDerivative · entry 1

Reed Joshua · CIK 0001746541 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

F2 · balance_after: Consists of 13,500 RSUs.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 22:19 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.36 $0.00
Disclosure

SEC source: 0001415889-24-018659 · form4-07012024_100750.xml · derivative · entry 3

Burow Kristina · CIK 0001569248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2034-06-27

F5 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 22:19 UTC GrantCommon Stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-018659 · form4-07012024_100750.xml · nonDerivative · entry 1

Burow Kristina · CIK 0001569248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,839

F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

F2 · balance_after: Consists of 5,339 shares of common stock and 13,500 RSUs.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:32 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.36 $0.00
Disclosure

SEC source: 0001415889-24-018649 · form4-07012024_090729.xml · derivative · entry 2

Vaishnaw Akshay · CIK 0001458494 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2034-06-27

F3 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:32 UTC GrantCommon Stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-018649 · form4-07012024_090729.xml · nonDerivative · entry 1

Vaishnaw Akshay · CIK 0001458494 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,955

F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

F2 · balance_after: Consists of 9,455 shares of common stock and 13,500 RSUs.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:28 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.36 $0.00
Disclosure

SEC source: 0001415889-24-018642 · form4-07012024_090740.xml · derivative · entry 3

Gilman Michael · CIK 0001291144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2034-06-27

F4 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:28 UTC GrantCommon Stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-018642 · form4-07012024_090740.xml · nonDerivative · entry 1

Gilman Michael · CIK 0001291144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

F2 · balance_after: Consists of 13,500 RSUs.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:27 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.36 $0.00
Disclosure

SEC source: 0001415889-24-018639 · form4-07012024_090707.xml · derivative · entry 3

FLIER JEFFREY S. · CIK 0001740266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2034-06-27

F4 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:27 UTC GrantCommon Stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-018639 · form4-07012024_090707.xml · nonDerivative · entry 1

FLIER JEFFREY S. · CIK 0001740266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,513

F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

F2 · balance_after: Consists of 9,013 shares of common stock and 13,500 RSUs.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:15 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.36 $0.00
Disclosure

SEC source: 0001415889-24-018631 · form4-07012024_090731.xml · derivative · entry 2

Brudnick Richard · CIK 0001692359 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2034-06-27

F3 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:15 UTC GrantCommon Stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-018631 · form4-07012024_090731.xml · nonDerivative · entry 1

Brudnick Richard · CIK 0001692359 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

F2 · balance_after: Consists of 13,500 RSUs.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:13 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.36 $0.00
Disclosure

SEC source: 0001415889-24-018629 · form4-07012024_090756.xml · derivative · entry 3

AKKARAJU SRINIVAS · CIK 0001253170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2034-06-27

F4 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:13 UTC GrantCommon Stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-018629 · form4-07012024_090756.xml · nonDerivative · entry 1

AKKARAJU SRINIVAS · CIK 0001253170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

F2 · balance_after: Consists of 13,500 RSUs.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:12 UTC
Hallal DavidDirector
GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.36 $0.00
Disclosure

SEC source: 0001415889-24-018627 · form4-07012024_090748.xml · derivative · entry 2

Hallal David · CIK 0001457477 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2034-06-27

F3 · derivative.exercise_date: Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 21:12 UTC
Hallal DavidDirector
GrantCommon Stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-018627 · form4-07012024_090748.xml · nonDerivative · entry 1

Hallal David · CIK 0001457477 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 304,095

F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.

F2 · balance_after: Consists of 290,595 shares of common stock and 13,500 RSUs.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 17:55 UTC SaleCommon Stock 4,305 $8.98 $38,679.99
Disclosure

SEC source: 0001415889-24-017483 · form4-06182024_090605.xml · nonDerivative · entry 1

Parlavecchio Caryn · CIK 0001922346 · CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,439

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on June 17, 2024. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on June 16, 2022. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over three years, subject to a continued service relationship with the Issuer on the applicable vesting date.

F2 · balance_after: Consists of 37,070 shares of common stock and 116,369 RSUs.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 21:56 UTC
Qatanani MoCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 2,315 $8.99 $20,800.28
Disclosure

SEC source: 0001415889-24-017485 · form4-06182024_090627.xml · nonDerivative · entry 1

Qatanani Mo · CIK 0001980298 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,704

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on June 17, 2024. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on June 16, 2022. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over three years, subject to a continued service relationship with the Issuer on the applicable vesting date.

F2 · balance_after: Consists of 15,607 shares of common stock and 129,097 RSUs.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 21:54 UTC SaleCommon Stock 9,458 $8.98 $84,978.24
Disclosure

SEC source: 0001415889-24-017481 · form4-06182024_090606.xml · nonDerivative · entry 1

Myles Edward H · CIK 0001358219 · COO & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,518

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on June 17, 2024. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on June 16, 2022. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over three years, subject to a continued service relationship with the Issuer on the applicable vesting date.

F2 · balance_after: Consists of 40,430 shares of common stock and 161,088 RSUs.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 21:53 UTC
Ho JunlinGENERAL COUNSEL
SaleCommon Stock 4,695 $8.98 $42,182.70
Disclosure

SEC source: 0001415889-24-017479 · form4-06182024_090656.xml · nonDerivative · entry 1

Ho Junlin · CIK 0001868114 · GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,076

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on June 17, 2024. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on June 16, 2022. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over three years, subject to a continued service relationship with the Issuer on the applicable vesting date.

F2 · balance_after: Consists of 74,259 shares of common stock and 129,817 RSUs.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:17 UTC
Nashat AmirDirector
OtherCommon Stock 37 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-058674 · ownership.xml · nonDerivative · entry 9

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,639

F7 · kind: Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the in-kind distribution of common stock of the Issuer for no consideration by PVM VI.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:17 UTC
Nashat AmirDirector
OtherCommon Stock 276 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-058674 · ownership.xml · nonDerivative · entry 8

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F6 · kind: Represents a distribution, and not a purchase or sale, without additional consideration by PVM VI to its members.

F5 · ownership.nature: The reportable securities are owned directly by PVM VI. PVM VI is the general partner of PVP VI and PVM VI is managed by the Managing Members. The Managing Members, one of whom is the Reporting Person and a member of the Issuer's Board of Directors, may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PVM VI. Each of the Reporting Person and the other Managing Members disclaim beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:17 UTC
Nashat AmirDirector
OtherCommon Stock 276 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-058674 · ownership.xml · nonDerivative · entry 7

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 276

F12 · kind: Represents a change in the form of ownership of PVM VI by virtue of the receipt of shares as a result of the in-kind distribution of common stock of the Issuer for no consideration by PVPFF VI.

F5 · ownership.nature: The reportable securities are owned directly by PVM VI. PVM VI is the general partner of PVP VI and PVM VI is managed by the Managing Members. The Managing Members, one of whom is the Reporting Person and a member of the Issuer's Board of Directors, may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PVM VI. Each of the Reporting Person and the other Managing Members disclaim beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:17 UTC
Nashat AmirDirector
OtherCommon Stock 322 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-058674 · ownership.xml · nonDerivative · entry 6

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,469

F10 · kind: Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the in-kind distribution of common stock of the Issuer for no consideration by PVPFF VI.

F11 · ownership.nature: The reportable securities are owned by North Star Profit Sharing Trust for the benefit of the Reporting Person.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:17 UTC
Nashat AmirDirector
OtherCommon Stock 27,606 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-058674 · ownership.xml · nonDerivative · entry 5

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 96,474

F8 · kind: Represents a distribution, and not a purchase or sale, without additional consideration by Polaris Venture Partners Founders' Fund VI, L.P. ("PVPFF VI") to its partners.

F9 · ownership.nature: The reportable securities are owned directly by PVPFF VI. PVM VI is the general partner of PVPFF VI. PVM VI may be deemed to have sole voting, investment and dispositive power with respect to the shares held by PVPFF VI and each of the Reporting Person and the other Managing Members may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PVPFF VI. Each of the Reporting Person, PVM VI and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person, PVM VI or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:17 UTC
Nashat AmirDirector
OtherCommon Stock 13,096 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-058674 · ownership.xml · nonDerivative · entry 4

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,602

F7 · kind: Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the in-kind distribution of common stock of the Issuer for no consideration by PVM VI.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:17 UTC
Nashat AmirDirector
OtherCommon Stock 98,257 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-058674 · ownership.xml · nonDerivative · entry 3

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F6 · kind: Represents a distribution, and not a purchase or sale, without additional consideration by PVM VI to its members.

F5 · ownership.nature: The reportable securities are owned directly by PVM VI. PVM VI is the general partner of PVP VI and PVM VI is managed by the Managing Members. The Managing Members, one of whom is the Reporting Person and a member of the Issuer's Board of Directors, may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PVM VI. Each of the Reporting Person and the other Managing Members disclaim beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:17 UTC
Nashat AmirDirector
OtherCommon Stock 98,257 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-058674 · ownership.xml · nonDerivative · entry 2

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 98,257

F4 · kind: Represents a change in the form of ownership of PVM VI by virtue of the receipt of shares in the in-kind distribution of common stock of the Issuer for no consideration by PVP VI.

F5 · ownership.nature: The reportable securities are owned directly by PVM VI. PVM VI is the general partner of PVP VI and PVM VI is managed by the Managing Members. The Managing Members, one of whom is the Reporting Person and a member of the Issuer's Board of Directors, may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PVM VI. Each of the Reporting Person and the other Managing Members disclaim beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:17 UTC
Nashat AmirDirector
OtherCommon Stock 472,394 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-058674 · ownership.xml · nonDerivative · entry 1

Nashat Amir · CIK 0001575843 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,650,953

F1 · kind: Represents a distribution, and not a purchase or sale, without additional consideration by Polaris Venture Partners VI, L.P. ("PVP VI") to its partners.

F2 · ownership.nature: The reportable securities are owned directly by PVP VI. Polaris Venture Management Co. VI, L.L.C. ("PVM VI") is the general partner of PVP VI and PVM VI is managed by its managing members, one of whom is the Reporting Person and a member of the Issuer's Board of Directors (collectively, the "Managing Members"). PVM VI may be deemed to have sole voting, investment and dispositive power with respect to the shares held by PVP VI and each of the Reporting Person and the other Managing Members may be deemed to have shared voting, investment and dispositive power with respect to the shares held by PVP VI. Each of the Reporting Person, PVM VI and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person, PVM VI or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose,

F3 · ownership.nature: (Continued from footnote 2) except to the extent of their respective pecuniary interests therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.